letrozole,palbociclib
pfizer,novartis
['paloma-2']
paloma-2 trial continue to make effort to show the impact to the overall survival. #asco22 
MD Anderson Cancer Ctr, Breast Med Oncologist, Section Chief of Translational Breast Cancer Research, Executive Director of IBC Program